Cat.#: ACPP-1368
| Despition | KCNJ2 Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1602 | Human AKR7A2 Protein (AC1602) | 5 µg | inquiry |
| ACPP-1672 | Human SERPINA3 Protein (AC1672) | 20 µg | inquiry |
| ACPP-1753 | Human SPR Protein (AC1753) | 5 µg | inquiry |
| ACPP-1524 | Human TARDBP (1-414) Protein (AC1524) | 5 µg | inquiry |
| ACPP-1287 | Dopamine Receptor D1 Blocking Peptide (AC1287) | 250 µg | inquiry |
| ACPP-1341 | Pax2 Blocking Peptide (AC1341) | 250 µg | inquiry |
| ACPP-1425 | Human CAMK4 Protein (AC1425) | 2 µg | inquiry |
| ACPP-1736 | Human DYNLL1 Protein (AC1736) | 5 µg | inquiry |
| ACPP-1505 | Human CRYGD Protein (AC1505) | 5 µg | inquiry |
| ACPP-1744 | Human C1q Protein (AC1744) | 200 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.